1 study found for:    S1108, A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237
Show Display Options
Rank Status Study
1 Active, not recruiting Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Hepatosplenic T-cell Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Non-Hodgkin Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma
Interventions: Drug: alisertib;   Other: pharmacological study;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years